Tyratech, Inc. has recently announced two further US distribution agreements for Vamousse, its lice treatment product.
Tyratech has now secured distribution deals with CVS Pharmacy, the second largest pharmacy chain in the US, and Walgreens, the largest pharmacy chain.
Coming after recent distribution agreements with Walmart as well as several pharmaceutical distributors, Vamousse is now placed with the top three distributors and three of the top four pharmacy retailers in the US market.
Vamousse is expected to be available in Walgreens from May 2015, and in CVS Pharmacy from April 2015.
Tyratech also announced an expanded UK distribution deal with Tesco.